Connect with us

Business Wire

Fortium Holdings Announces Rebranding to White River Energy

Published

on


Fortium Holdings Corp formally changes its name to White River Energy Corp

Rebranding initiative in line with strategic initiative to focus exclusively as a vertically integrated oil and gas exploration and production company

FAYETTEVILLE, Ark.–(BUSINESS WIRE)–Fortium Holdings Corp (OTC: FRTM), today announced that following majority shareholder approval on September 16, 2022, it formally changed its name to White River Energy Corp (“White River”). Additionally, White River has formally discontinued operations in its cannabis business, Elysian Premium Corp, and its retail sporting goods business, Norr LLC, and has divested both subsidiaries. White River has submitted an application to the Financial Industry Regulatory Authority to change its trading symbol.

“We are excited to announce this rebranding and renaming initiative so we can focus all efforts on developing our more than 30,000 acres of oil and gas mineral leases in Louisiana and Mississippi through a vertically integrated business model,” stated Randy May, White River Executive Chairman.

Jay Puchir, White River CEO added, “We believe that divesting from these nascent businesses is in the best interest of the Company and our shareholders.”

About White River Energy Corp

White River’s principal subsidiary is White River Holdings Corp. which is engaged in oil and gas exploration, production, and drilling operations on over 30,000 cumulative acres of active mineral leases in Louisiana and Mississippi.

Contacts

Fortium Holdings Investors:

IR@fortium-holdings.com or 1-800-203-5610

This post was originally published on this site



Source link

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published.

Business Wire

Outlook on the CBD Consumer Health Global Market to 2027 – by Product, Distribution Channel and Region – ResearchAndMarkets.com

Published

on

By


DUBLIN–(BUSINESS WIRE)–The “CBD Consumer Health Market Intelligence Report – Global Forecast to 2027” report has been added to ResearchAndMarkets.com’s offering.

The Global CBD Consumer Health Market is projected to reach USD 19,338.49 million by 2027 from USD 8,061.86 million in 2021, at a CAGR 15.69% during the forecast period.

Market Statistics:

The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available.

In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

  • The Americas CBD Consumer Health Market size was estimated at USD 3,660.98 million in 2021, is expected to reach USD 4,182.25 million in 2022, and is projected to grow at a CAGR of 15.27% to reach USD 8,589.65 million by 2027.
  • The Asia-Pacific CBD Consumer Health Market size was estimated at USD 1,590.92 million in 2021, is expected to reach USD 1,881.85 million in 2022, and is projected to grow at a CAGR of 16.59% to reach USD 3,996.03 million by 2027.
  • The Europe, Middle East & Africa CBD Consumer Health Market size was estimated at USD 2,809.95 million in 2021, is expected to reach USD 3,249.15 million in 2022, and is projected to grow at a CAGR of 15.73% to reach USD 6,752.80 million by 2027.

Market Segmentation & Coverage:

The report on cbd consumer health identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group’s economies and geographies can help gain business acumen for better strategic decision-making.

This market coverage across different industry verticals reveals the hidden truth about the players’ strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for your market plan.

This research report categorizes the cbd consumer health to forecast the revenues and analyze the trends in each of the following sub-markets:

Product:

  • Medical OTC Products
    • CBD Analgesic Products
    • CBD Dermatology Products
    • CBD Mental Health Products
    • CBD Sleeping Aids Products
  • Nutraceuticals
    • CBD Sports Nutrition
    • CBD Vitamins and Dietary Supplements (VDS)
    • CBD Weight Management and Wellbeing

Distribution Channel:

  • Online
  • Retail Pharmacies
  • Retail Stores

Region:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • Arizona
      • California
      • Colorado
      • Florida
      • Illinois
      • Massachusetts
      • Michigan
      • Nevada
      • Ohio
      • Oregon
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
  • Europe, Middle East & Africa
    • France
    • Germany
    • Italy
    • Netherlands
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • United Arab Emirates
    • United Kingdom

Company Usability Profiles:

  • Aurora Cannabis Inc.
  • Biovectra Inc.
  • Canopy Growth Corporation
  • CBD American Shaman
  • CBDepot s.r.o
  • Charlotte’s Web Holdings, Inc.
  • CURE Pharmaceutical Holding Corp.
  • CV Sciences, Inc.
  • Elixinol LLC
  • Endoca BV
  • Gaia Botanicals, LLC
  • Global Cannabinoids Inc.
  • HEXO Corp.
  • Isodiol International Inc.
  • Jazz Pharmaceuticals, Inc.
  • Joy Organics Private Limited
  • Kazmira LLC
  • Medical Marijuana, Inc.
  • Medterra CBD, LLC.
  • NuLeaf Naturals, LLC
  • Redwood Wellness, LLC

For more information about this report visit https://www.researchandmarkets.com/r/jpe4r1

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

This post was originally published on this site



Source link

Continue Reading

Business Wire

Brown-Forman to Purchase Diplomático Rum Brand

Published

on

By


Global Super-Premium Rum Brand and Related Assets to Join Portfolio

LOUISVILLE, Ky.–(BUSINESS WIRE)–Brown-Forman Corporation (NYSE:BFA, BFB) announced today it has reached an agreement to purchase the Diplomático Rum brand and related assets from Destillers United Group S.L. (Spain). Upon completion of the transaction, Brown-Forman will add the Diplomático Rum family of brands to its portfolio and acquire a production facility located in Panama.


The Diplomático Rum family of brands is the No. 1 super- and ultra-premium rum and the No. 2 super-premium+ rum worldwide (IWSR, 2021). Super-premium+ rum has grown at an annual rate of 17% over the past five years, with rum accounting for approximately 8% of global spirits.

“Diplomático Rum will join our expanding portfolio, giving Brown-Forman a market leading entry into the fast-growing super-premium rum category. This aged rum brand has distinctive packaging, strong brand positioning, and is a delicious tasting spirit,” said Lawson Whiting, President and CEO, Brown-Forman Corporation. “As part of this acquisition, we will welcome more than 100 new employees to Brown-Forman.”

Destillers United Group S.L. will continue to produce and age the unique, carefully-crafted, and complex Diplomático Rum in their original distillery at the foot of the Andes mountains.

“We are proud to have pioneered and been instrumental in developing the super-premium+ rum category around the world. Diplomático Rum is ready to accelerate its growth with Brown-Forman, one of the world’s most well-known spirits and wines companies,” stated Destillers United Group S.L., current owner of the Diplomático Rum brand. “We share a similar familial culture and know the brand will continue building on our legacy. We look forward to working together to bring Diplomático Rum to consumers around the world.”

Diplomático Rum is sold in more than 100 countries. Top markets include France, Germany, and the United States.

Diplomático Rum consists of three ranges of complex rums. The Traditional Range includes Planas, Mantuano, Reserva Exclusiva, and Selección de Familia. The Prestige Range includes Single Vintage and Diplomático Ambassador, both aged 12 years and finished in Spanish sherry casks. The Distillery Collection includes a range of three limited production bottlings that showcase the distillery’s unique distillation methods.

The transaction, which is subject to customary closing conditions, is expected to close within 90 days.

Photo: Diplomático Rum

About Diplomático Rum:

Diplomático is a super-premium rum from Venezuela. In 2018, Diplomático was awarded Wine Enthusiast’s prestigious “Spirit Brand of the Year,” the first-ever rum to win in this category. The Diplomático Rum distillery is located at the foot of the Andes Mountains and is family-owned. Diplomático Rum’s distillery combines traditional methods with modern technology to produce the finest of rums. The production area boasts great conditions for sugar cane and rum production including fertile lands, abundant water, and a Caribbean climate.

www.ronDiplomático.com, @Diplomático rum

About Brown-Forman:

For more than 150 years, Brown-Forman Corporation has enriched the experience of life by responsibly building fine quality beverage alcohol brands, including Jack Daniel’s Tennessee Whiskey, Jack Daniel’s Tennessee RTDs, Jack Daniel’s Tennessee Honey, Jack Daniel’s Tennessee Fire, Jack Daniel’s Tennessee Apple, Gentleman Jack, Jack Daniel’s Single Barrel, Woodford Reserve, Old Forester, Coopers’ Craft, The GlenDronach, Benriach, Glenglassaugh, Slane, Herradura, el Jimador, New Mix, Korbel, Sonoma-Cutrer, Finlandia, Chambord, and Fords Gin. Brown-Forman’s brands are supported by approximately 5,200 employees globally and sold in more than 170 countries worldwide. For more information about the company, please visit brown-forman.com. Follow us on Twitter, Instagram, and LinkedIn.

About Destillers United Group S.L.:

For more than 20 years, Destillers United Group (DUG) has produced Diplomático Rum with passion using their expertise in combining modern and traditional distillation methods to produce exceptional rums for demanding palates. DUG’s identity is forged through a commitment to quality, making rums and other beverage alcohol brands, including Canaima Gin, CocuySoroche, Cinco Estrellas, Rumba Ron; as well other rum liquors, whiskies, whiskies liquors, Brandy, Vodkas, Vodka Liquors, Anis, Wellington Gin, Bitters, Mixers, and Aperitives. DUG brands are supported by approximately 600 employees globally and are sold in more than 100 countries worldwide.

Important Information on Forward-Looking Statements:

In these notes, “we,” “us,” “our,” and the “Company” refer to Brown-Forman Corporation and its consolidated subsidiaries, collectively. This report contains statements, estimates, and projections that are “forward-looking statements” as defined under U.S. federal securities laws. Words such as “aim,” “anticipate,” “aspire,” “believe,” “can,” “continue,” “could,” “envision,” “estimate,” “expect,” “expectation,” “intend,” “may,” “might,” “plan,” “potential,” “project,” “pursue,” “see,” “seek,” “should,” “will,” “would,” and similar words indicate forward-looking statements, which speak only as of the date we make them. Except as required by law, we do not intend to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise. By their nature, forward-looking statements involve risks, uncertainties, and other factors (many beyond our control) that could cause our actual results to differ materially from our historical experience or from our current expectations or projections.

These risks and uncertainties include, but are not limited to:

  • Failure to obtain required regulatory approvals related to the Transaction in a timely manner or otherwise
  • Failure to satisfy any closing condition to the proposed acquisition of the Diplomático Business
  • Risks associated with tax liabilities or changes in U.S. federal or foreign tax laws or interpretation to which the proposed acquisition of the Diplomático Business or the parties thereto are subject
  • Failure to successfully integrate the Diplomático Business
  • Failure to realize anticipated benefits of any combined operations
  • Unanticipated costs of acquiring or integrating the Diplomático Business
  • Potential impact of announcement or consummation of the proposed acquisition of the Diplomático Business on relationships with third parties, including employees, customers, suppliers, partners and competitors
  • The outcome of any legal proceedings that may be instituted against us following the announcement of the Transaction
  • The occurrence of any event, change or other circumstance that could give rise to the termination of the Purchase Agreement or that could otherwise cause the transactions contemplated therein to fail to close
  • Our substantial dependence upon the continued growth of the Jack Daniel’s family of brands
  • Substantial competition from new entrants, consolidations by competitors and retailers, and other competitive activities, such as pricing actions (including price reductions, promotions, discounting, couponing, or free goods), marketing, category expansion, product
  • introductions, or entry or expansion in our geographic markets or distribution networks
  • Route-to-consumer changes that affect the timing of our sales, temporarily disrupt the marketing or sale of our products, or result in higher fixed costs
  • Disruption of our distribution network or inventory fluctuations in our products by distributors, wholesalers, or retailers
  • Changes in consumer preferences, consumption, or purchase patterns – particularly away from larger producers in favor of small distilleries or local producers, or away from brown spirits, our premium products, or spirits generally, and our ability to anticipate or react to them; further legalization of marijuana; shifts in consumer purchase practices; bar, restaurant, travel, or other on-premise declines; shifts in demographic or health and wellness trends; or unfavorable consumer reaction to new products, line extensions, package changes, product reformulations, or other product innovation
  • Production facility, aging warehouse, or supply chain disruption
  • Imprecision in supply/demand forecasting
  • Higher costs, lower quality, or unavailability of energy, water, raw materials, product ingredients, or labor
  • Impact of health epidemics and pandemics, including the COVID-19 pandemic, and the risk of the resulting negative economic impacts and related governmental actions
  • Unfavorable global or regional economic conditions, particularly related to the COVID-19 pandemic, and related economic slowdowns or recessions, low consumer confidence, high unemployment, weak credit or capital markets, budget deficits, burdensome government debt, austerity measures, higher interest rates, higher taxes, political instability, higher inflation, deflation, lower returns on pension assets, or lower discount rates for pension obligations
  • Product recalls or other product liability claims, product tampering, contamination, or quality issues
  • Negative publicity related to our company, products, brands, marketing, executive leadership, employees, Board of Directors, family stockholders, operations, business performance, or prospects
  • Failure to attract or retain key executive or employee talent
  • Risks associated with acquisitions, dispositions, business partnerships, or investments – such as acquisition integration, termination difficulties or costs, or impairment in recorded value
  • Risks associated with being a U.S.-based company with a global business, including commercial, political, and financial risks; local labor policies and conditions; protectionist trade policies, or economic or trade sanctions, including additional retaliatory tariffs on American whiskeys and the effectiveness of our actions to mitigate the negative impact on our margins, sales, and distributors; compliance with local trade practices and other regulations; terrorism; and health pandemics
  • Failure to comply with anti-corruption laws, trade sanctions and restrictions, or similar laws or regulations
  • Fluctuations in foreign currency exchange rates, particularly a stronger U.S. dollar
  • Changes in laws, regulatory measures, or governmental policies – especially those that affect the production, importation, marketing, labeling, pricing, distribution, sale, or consumption of our beverage alcohol products
  • Tax rate changes (including excise, corporate, sales or value-added taxes, property taxes, payroll taxes, import and export duties, and tariffs) or changes in related reserves, changes in tax rules or accounting standards, and the unpredictability and suddenness with which they can occur
  • Decline in the social acceptability of beverage alcohol in significant markets
  • Significant additional labeling or warning requirements or limitations on availability of our beverage alcohol products
  • Counterfeiting and inadequate protection of our intellectual property rights
  • Significant legal disputes and proceedings, or government investigations
  • Cyber breach or failure or corruption of our key information technology systems or those of our suppliers, customers, or direct and indirect business partners, or failure to comply with personal data protection laws
  • Our status as a family “controlled company” under New York Stock Exchange rules, and our dual-class share structure

For further information on these and other risks, please see the risks and uncertainties described in Part I, Item 1A. Risk Factors of our fiscal 2022 Form 10-K and those described from time to time in our future reports filed with the Securities and Exchange Commission (SEC).

Contacts

Brown-Forman: Elizabeth Conway, elizabeth_conway@b-f.com
Diplomático Rum: diplomático@komunikalatam.com
Diplomático Rum: amunoz@kreab.com

This post was originally published on this site





Source link

Continue Reading

Business Wire

 Columbia Care Introduces Hedy, a New Cannabis-Infused Edibles Brand

Published

on

By


Hedy will become the unifying brand for all Columbia Care edible products across the country

NEW YORK–(BUSINESS WIRE)–Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), one of the largest and most experienced cultivators, manufacturers and providers of cannabis products in the U.S., announced it has launched its new cannabis-infused edibles brand, Hedy, in six markets. A variety of fast-acting chocolates and gummies are now available in Arizona, Colorado, Delaware, Massachusetts, Missouri and Virginia.

“We are so excited to bring Hedy to life and share with our patients and customers across the country. Our team wanted to create a brand, as well as a bright, fun and inviting visual representation that truly reflects the uplifting edibles experience,” said BJ Carretta, SVP of Brands, Columbia Care. “Everything from the packaging to the flavors, and eventually the various forms underneath the brand, are all part of this authentic interaction with Hedy. We developed the brand in coordination with our cultivation and marketing teams, using insights generated from our unique technological platforms, such as Forage, that help us better understand what our community is looking for. We believe this is the right product to meet our patients and customers where they are in their cannabis journey, with an approachable form factor that is of the highest quality and designed to provide a consistent experience, no matter the market.”

In its first six markets, Hedy gummies will be available in three flavors: cherry lime, green apple and watermelon. Colorado has also launched chocolate drops. The 5mg or 10mg THC gummies come in packages of 10 or 20, depending on the market, and are powered by leading edibles ingredient company Azuca and its fast-acting TiME INFUSION™ formulations to provide quick-onset in 5-15 minutes.

In the coming months, the Company will introduce more options, and will have Hedy available in more markets. Additionally, existing Columbia Care edible brands such as NectarBee, will be converting to the Hedy brand over time.

For more information about Hedy, visit www.hedyedibles.com.

About Columbia Care

Columbia Care is one of the largest and most experienced cultivators, manufacturers and providers of cannabis products and related services, with licenses in 18 U.S. jurisdictions. Columbia Care operates 131 facilities including 99 dispensaries and 32 cultivation and manufacturing facilities, including those under development. Columbia Care is one of the original multi-state providers of medical cannabis in the U.S. and now delivers industry-leading products and services to both the medical and adult-use markets. In 2021, the company launched Cannabist, its new retail brand, creating a national dispensary network that leverages proprietary technology platforms. The company offers products spanning flower, edibles, oils and tablets, and manufactures popular brands including Seed & Strain, Triple Seven, Hedy, gLeaf, Classix, Press, Amber and Platinum Label CBD. For more information on Columbia Care, please visit www.columbia.care.

Caution Concerning Forward-Looking Statements

This press release contains certain statements that constitute “forward-looking information” or “forward-looking statements” within the meaning of applicable securities laws and reflect the Company’s current expectations regarding future events. Forward-looking statements or information contained in this release include, but are not limited to, statements or information with respect to the Company’s ability to execute on retail, wholesale, brand and product initiatives. These forward-looking statements or information, which although considered reasonable by the Company, may prove to be incorrect and are subject to known and unknown risks and uncertainties that may cause actual results, performance or achievements of the Company to be materially different from those expressed or implied by any forward-looking information. These risks, uncertainties and other factors include, among others, favorable operating and economic conditions; obtaining and maintaining all required licenses and permits; favorable production levels and sustainable costs from the Company’s operations; and the level of demand for cannabis products, including the Company’s products sold by third parties. In addition, securityholders should review the risk factors discussed under “Risk Factors” in Columbia Care’s Form 10 dated May 9, 2022, filed with the applicable securities regulatory authorities and described from time to time in documents filed by the Company with Canadian and U.S. securities regulatory authorities.

Contacts

Investor Contact
Lee Ann Evans

Capital Markets

ir@col-care.com

Media Contact
Lindsay Wilson

Communications

+1.978.662.2038

media@col-care.com

This post was originally published on this site



Source link

Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media